Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mavligit

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Transplantation Proceedings|September 1, 1973
Host defense, chemical immunosuppression, and the transplant recipient. Relative effects of intermittent versus continuous immunosuppressive therapy with reference to the objectives of treatmentE M Hersh, J U Gutterman, G Mavligit, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Immunotherapy for recurrent malignant melanoma: efficacy of BCG in prolonging the postoperative disease-free interval and survivalJ U Gutterman, S P Richman, C M McBride, et al.
Cardiovascular and Interventional Radiology|January 1, 1981
The therapy of osteosarcoma by intraarterial cis-platinum an limb preservationV P Chuang, S Wallace, R S Benjamin, et al.
Lancet (London, England)|December 14, 1974
Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.GJ U Gutterman, E M Hersh, V Rodriguez, et al.
Cancer Research|August 1, 1974
Prognostic correlations and response to treatment in advanced metastatic malignant melanomaL H Einhorn, M A Burgess, C Vallejos, et al.
Cancer|October 15, 1982
The natural history of resectable metastatic melanoma (Stage IVA melanoma)L G Feun, J Gutterman, M A Burgess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervixA P Kudelka, T Levy, C F Verschraegen, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Transplantation Proceedings|September 1, 1973
Host defense, chemical immunosuppression, and the transplant recipient. Relative effects of intermittent versus continuous immunosuppressive therapy with reference to the objectives of treatmentE M Hersh, J U Gutterman, G Mavligit, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Immunotherapy for recurrent malignant melanoma: efficacy of BCG in prolonging the postoperative disease-free interval and survivalJ U Gutterman, S P Richman, C M McBride, et al.
Cardiovascular and Interventional Radiology|January 1, 1981
The therapy of osteosarcoma by intraarterial cis-platinum an limb preservationV P Chuang, S Wallace, R S Benjamin, et al.
Lancet (London, England)|December 14, 1974
Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.GJ U Gutterman, E M Hersh, V Rodriguez, et al.
Cancer Research|August 1, 1974
Prognostic correlations and response to treatment in advanced metastatic malignant melanomaL H Einhorn, M A Burgess, C Vallejos, et al.
Cancer|October 15, 1982
The natural history of resectable metastatic melanoma (Stage IVA melanoma)L G Feun, J Gutterman, M A Burgess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervixA P Kudelka, T Levy, C F Verschraegen, et al.
Pageof 5